Risk Management Plan Summit -

Risk Management Plan Summit
11–12 October 2017
London, United Kingdom

Plan, Implement and Execute Compliant RMPs that Improve Patient Safety

Agenda – Risk Management Plan Summit



Day One

 Wednesday 11 October

9:15 – 9:30

Chairperson’s Opening Remarks


Carla Perdun Barrett, Executive Director, Global Risk Management, ALLERGAN

9:30 – 10:30

Create and Implement Risk Management Plans Within Globally Dispersed Teams


Ruth Dixon, Director, Safety Evaluation and Risk Management, GLAXOSMITHKLINE
Kandra Weller, Global Head of RMP Office, NOVARTIS

10:30 – 11:15

Risk Minimisation Measures: From Regulatory Framework to Practice


Annalisa Rubino, Ph.D., Senior Research Scientist, Evidera

11:15 – 11:45

Networking Break


11:45 – 12:30

Harmonise Global Risk Management (RM) Strategies


Carla Perdun Barrett, Executive Director, Global Risk Management, ALLERGAN

12:30 – 13:30

Luncheon


13:30 – 14:15

Incorporate and Maintain Global Oversight of RMP Implementation and Maintenance


Jane Feron, Risk Management Director, ASTRAZENECA

14:15 – 15:00

Technology Case Study: Examine Celgene’s Global Risk Management Technology Strategy


Paul Sheehan, Executive Director, Head of U.S. REMS, CELGENE

15:00 – 15:30

Networking Break


15:30 – 16:00

Develop and Deliver Effective Evaluation of Risk Minimisation Measures


Michael von Forstner, Co-Chair, Pharmacovigilance Working Group, MEDICINES FOR EUROPE

16:00 – 16:45

Monitoring of the Efficacy of Risk Management Measures


Emanuel Lohrmann, Lead Safety Physician, Boehringer Ingelheim


Day Two

 Thursday 12 October

8:45 – 9:00

Chairperson’s Recap of Day One


Carla Perdun Barrett, Executive Director, Global Risk Management, ALLERGAN

9:00 – 9:45

Incorporate Novel Approaches in Real-World Data (RWD) to Evaluate Risk Minimisation (RM) Interventions


Rachel Sobel, Senior Director, Epidemiology - Group Lead Global Innovative Pharma, PFIZER

9:45 – 11:15

Bridge the Divide to Manage Risk: Merge Health and Mobile Technologies to Link Prescriber, Pharmacy and Patient Experiences


Michael Wolf, Professor, Medicine and Learning Sciences Associate Division Chief – Research Division of General Internal Medicine, Feinberg School of Medicine, NORTHWESTERN UNIVERSITY
Stacy Bailey, Assistant Professor, Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, UNC AT CHAPEL HILL

11:15 – 11:45

Networking Break


11:45 – 12:30

Glean Lessons for Leveraging mHealth, Social Media and Mobile Apps by Exploring the Experiences of a Cross-Functional Panel


Panelists:
Michael Wolf, Professor, Medicine and Learning Sciences Associate Division Chief – Research Division of General Internal Medicine, Feinberg School of Medicine, NORTHWESTERN UNIVERSITY
Sumit Munjal, Senior Medical Director, EU+ Marketed Products, Global Pharmacovigilance, TAKEDA PHARMACEUTICALS
Stacy Cooper Bailey, PhD MPH, Assistant Professor, Division of Pharmaceutical Outcomes and Policy, UNC ESHELMAN SCHOOL OF PHARMACY

12:30 – 13:30

Luncheon


13:30 – 14:15

Improve the Impact of Communications by Extrapolating Key Practices From Marketing and Tailoring RMM Tools and Messaging


Matthias Hoffman, Senior Risk Management and Epidemiology Specialist, MUNDIPHARMA RESEARCH GMBH

14:15 – 15:15

Examine the Development and Evolution of an RMP Over the Course of a Product Lifecycle


Budhesh Dhamija, Senior Regulatory Affairs Professional — Victoza Team, NOVO NORDISK
Marcus Schartau, Safety Surveillance Risk Management Specialist, NOVO NORDISK

15:15 –

Chairperson’s Closing Remarks


Carla Perdun Barrett, Executive Director, Global Risk Management, ALLERGAN


live chat software